Amcor plc
Thesis
Amcor is a well-run, defensively positioned packaging manufacturer with credible cost-synergy delivery from its Berry Global merger, but its balance sheet leverage turns a solid operating business into a higher-variance equity. Net debt of roughly 3.5 times EBITDA means any shortfall in synergy capture or a slower-than-planned deleveraging path flows through to equity value at an amplified rate. The core question for investors is whether the current price offers enough cushion for that leverage risk.
The Business
Amcor became the world's largest consumer packaging company after completing its merger with Berry Global in April 2025. The group now operates through two segments: Flexible packaging (around 55% of revenue) serving food, healthcare and beauty customers, and Rigid packaging (around 45%) covering bottles, closures and dispensing systems. It runs more than 400 facilities across over 40 countries, with no single customer accounting for more than 10% of revenue. Its defining advantage is scale: Amcor is roughly twice the size of its nearest flexible-packaging competitor, which underpins its ability to negotiate raw material contracts and consolidate manufacturing plants.
Recent Performance
Reported revenue jumped 56.6% in FY26 to US$23.5 billion, entirely a function of consolidating Berry's operations rather than organic demand, since underlying volumes actually fell 2% for the year before recovering to +0.5% in the fourth quarter. EBITDA margin still expanded from 14.6% to 15.6% as US$240 million of merger synergies landed ahead of schedule, offsetting elevated resin costs. Management revised full-year free cash flow guidance downward mid-year, a caution flag on working capital during integration.
Outlook
Revenue growth is expected to normalise to low single digits over the next three years, reflecting genuine volume recovery rather than further merger step-ups. Margin expansion is the bigger earnings driver over that period, as the remaining synergies from the Berry merger flow through toward the company's multi-year target, a structural improvement since it stems from permanent plant closures and renegotiated procurement contracts rather than temporary cost cuts. Alongside that margin recovery, management expects a gradual deleveraging path as free cash flow after dividends is directed toward debt reduction.
Key Risks
Three risks dominate the thesis. A synergy shortfall, if cultural friction between the Amcor and Berry workforces or further executive turnover caps realised cost savings well below target, would stall both margin expansion and the deleveraging path at the same time. A refinancing risk sits in the US$3.4 billion of debt maturing between FY28 and FY30, which would carry a materially higher interest cost if refinanced at rates near the top of their recent range. A third risk is that FY26's organic volume decline reflects a structural reduction in packaging intensity by brand owners rather than ordinary cyclical destocking, in which case the recovery seen in the fourth quarter would not persist.
What to Watch
- Q1 CY2027 First transition-period quarterly results — the thesis-defining event, confirming whether the fourth-quarter volume recovery and synergy run-rate are sustained rather than one-off.
- 1-2 years Portfolio divestitures from the US$2.5 billion non-core review — asset sales at reasonable multiples could accelerate deleveraging.
- 2-3 years Leverage falling meaningfully below current levels — could support a re-rating of the equity multiple.
Latest Developments
Amcor's FY26 result showed margin expansion ahead of plan alongside a mid-year downgrade to free cash flow guidance, a combination that leaves the market divided between crediting the cost story and discounting the cash conversion. The company is transitioning its reporting year end from June to December, meaning the next results will cover a half-year bridging period rather than a standard comparable quarter.
Business
Company Description
Amcor plc is a Jersey-domiciled, dual-listed (NYSE and ASX) global packaging manufacturer, formed into its current shape by the April 2025 merger with Berry Global. The enlarged group operates two segments. Flexible packaging, around 55% of revenue, produces films, pouches and laminates for food, healthcare and personal care customers. Rigid packaging, around 45% of revenue, makes bottles, containers, closures and dispensing systems, primarily for beverages, home and personal care. Amcor reports in US dollars; per-share figures in this report are US dollars unless marked A$. The combined business spans more than 400 manufacturing sites in over 40 countries, giving it geographic and category diversification that few packaging peers can match.
Where the Growth Is
The single largest earnings driver over the next three years is cost synergy delivery from the Berry merger, targeted at US$650 million by year three. US$240 million had already landed 14 months post-close, ahead of the original schedule, driven by procurement consolidation and plant closures. The remaining synergy capture is expected to be the primary source of earnings per share growth over that period, alongside a secondary tailwind from mix shift toward faster-growing healthcare and beauty packaging categories.
Competitive Position
Amcor's competitive position rests on scale rather than pricing power. At roughly twice the size of its nearest flexible-packaging competitor, it can negotiate raw material contracts and rationalise manufacturing footprint in ways smaller players cannot easily replicate. Customer relationships typically involve 12-18 month product qualification cycles, creating switching costs that support high retention, and no single customer represents more than 10% of group revenue, limiting concentration risk. These advantages are real but incremental rather than structural: the packaging industry remains fragmented enough that competitors can still compete on price in commoditised categories, and Amcor's advantage is expected to persist for the next five to seven years rather than indefinitely, requiring continued execution to defend rather than a one-off structural barrier.
Management & Capital Discipline
Management's capital allocation priority since the merger has been deleveraging first, with dividends maintained at a 60-65% payout ratio and no share buybacks until net debt falls below 2.5 times EBITDA. This is a conservative sequencing that puts balance sheet repair ahead of shareholder returns beyond the existing dividend. Management has delivered credibly on the cost side, with synergies running ahead of the original timeline. Less comfortably, both the chief financial officer and chief operating officer departed within 18 months of the merger closing, a level of executive turnover during the most sensitive phase of integration that creates genuine key-person risk even though it has not yet visibly disrupted execution.
Financial Position
Net debt sits at roughly 3.5 times EBITDA, elevated for the sector but consistent with the scale of the Berry acquisition, and management's base case sees this falling toward 2.5 times by CY2030 through free cash flow after dividends. Around 85% of debt is fixed rate, limiting near-term exposure to higher interest rates, and a US$2.5 billion undrawn revolving facility provides a liquidity buffer. The balance sheet can weather a moderate downturn, but a US$3.4 billion maturity wall between FY28 and FY30 means the company is not free of refinancing risk, only that it is well-insulated in the near term.
Read the full report
Our complete analysis of Amcor plc includes: